PROS1 and COVID-19: Due to the structural similarities among the S proteins of MERS-CoV, SARS-CoV, and SARS-CoV-2, K986P/V987P were directly applied to engineer the prefusion-stabilized SARS-CoV-2 S during COVID-19 vaccine development.